Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Ritchie

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Current Opinion in Immunology|February 19, 2014
Allogeneic transplantation as anticancer immunotherapySimrit Parmar, David S Ritchie
Cell|July 28, 2009
A new therapeutic target for leukemia comes to the surfaceDavid S Ritchie, Mark J Smyth
Nature Reviews. Immunology|August 9, 2014
Natural killer T cells: drivers or passengers in preventing human disease?Stuart P Berzins, David S Ritchie
Oncoimmunology|June 28, 2012
Are the immuno-stimulatory properties of Lenalidomide extinguished by co-administration of Dexamethasone?Andy Hsu, David S Ritchie, Paul Neeson
European Journal of Haematology|September 13, 2002
Aplastic anemia as a late complication of thymoma in remissionDavid S Ritchie, Craig Underhill, Andrew P Grigg
Immunotherapy|July 20, 2010
Drug-mediated and cellular immunotherapy in multiple myelomaDavid S Ritchie, Hang Quach, Kate Fielding, et al.
International Journal of Molecular Sciences|May 31, 2020
Association between P2X7 Polymorphisms and Post-Transplant Outcomes in Allogeneic Haematopoietic Stem Cell TransplantationRachel M Koldej, Travis Perera, Jenny Collins, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 29, 2024
Modified cell trace violet proliferation assay preserves lymphocyte viability and allows spectral flow cytometry analysisJoanne E Davis, Mandy Ludford-Menting, Rachel Koldej, et al.
International Journal of Laboratory Hematology|March 6, 2020
Diagnostic evaluation and considerations in hypocellular bone marrow failure-A focus on genomicsLucy C Fox, Erica M Wood, David S Ritchie, et al.
Leukemia Research|June 21, 2007
Glycolytic metabolism confers resistance to combined all-trans retinoic acid and arsenic trioxide-induced apoptosis in HL60rho0 cellsPatries M Herst, Elizabeth L Hesketh, David S Ritchie, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Current Opinion in Immunology|February 19, 2014
Allogeneic transplantation as anticancer immunotherapySimrit Parmar, David S Ritchie
Cell|July 28, 2009
A new therapeutic target for leukemia comes to the surfaceDavid S Ritchie, Mark J Smyth
Nature Reviews. Immunology|August 9, 2014
Natural killer T cells: drivers or passengers in preventing human disease?Stuart P Berzins, David S Ritchie
Oncoimmunology|June 28, 2012
Are the immuno-stimulatory properties of Lenalidomide extinguished by co-administration of Dexamethasone?Andy Hsu, David S Ritchie, Paul Neeson
European Journal of Haematology|September 13, 2002
Aplastic anemia as a late complication of thymoma in remissionDavid S Ritchie, Craig Underhill, Andrew P Grigg
Immunotherapy|July 20, 2010
Drug-mediated and cellular immunotherapy in multiple myelomaDavid S Ritchie, Hang Quach, Kate Fielding, et al.
International Journal of Molecular Sciences|May 31, 2020
Association between P2X7 Polymorphisms and Post-Transplant Outcomes in Allogeneic Haematopoietic Stem Cell TransplantationRachel M Koldej, Travis Perera, Jenny Collins, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 29, 2024
Modified cell trace violet proliferation assay preserves lymphocyte viability and allows spectral flow cytometry analysisJoanne E Davis, Mandy Ludford-Menting, Rachel Koldej, et al.
International Journal of Laboratory Hematology|March 6, 2020
Diagnostic evaluation and considerations in hypocellular bone marrow failure-A focus on genomicsLucy C Fox, Erica M Wood, David S Ritchie, et al.
Leukemia Research|June 21, 2007
Glycolytic metabolism confers resistance to combined all-trans retinoic acid and arsenic trioxide-induced apoptosis in HL60rho0 cellsPatries M Herst, Elizabeth L Hesketh, David S Ritchie, et al.
Pageof 7